Approval · Notice of Compliance 8630 · 2007
DUODOPA: Notice of Compliance 8630
Issued March 1, 2007
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
Issued with conditions (NOC/c): the company must confirm the benefit in further studies.
- Notice number
- 8630
- Date
- March 1, 2007
- Company
- Solvay Pharma Inc.Saint-Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Antiparkinson agent
- With conditions
- Yes (NOC/c)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| DUODOPA | 02292165 | Marketed |
Medicinal ingredients
- LEVODOPA 20 MG per ML
- CARBIDOPA MONOHYDRATE 5 MG per ML